Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisor
Merck Animal Health has acquired a controlling stake in Vallée S.A.
Merck Animal Health has acquired a controlling stake in Vallée S.A.
Learn moreSulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.
Learn moreCentro Diagnóstico Boris Berenstein has been acquired by DASA
The Berenstein family has sold Centro Diagnóstico Boris Berenstein (CDBB) to Diagnósticos da America S.A. (DASA).
Learn more
Boris Berenstein
Former Owner and President, Centro Diagnóstico Boris Berenstein
Read more
Businesses are shaping the future through M&A
QUARTERLY M&A ACTIVITY: In 2024's Q4, Oaklins completed 90 M&A transactions, with TMT and Healthcare leading, reflecting innovation and strategic growth.
Learn more
Talk to our local advisors
Meet our global industry specialists
Michael S. Goldman
Oaklins TM Capital